CGC

Canopy Growth

CGC

Market cap $424M

Overview Fund Activity

1.36 USD

-0.09

6.21%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

1.37

+0.01

0.74%

1 day

-6.21%

5 days

-1.45%

1 month

-0.73%

3 months

3.03%

6 months

15.25%

Year to date

-52.78%

1 year

-72.19%

5 years

-99.17%

10 years

-99.52%

About: Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

Employees: 960

Healthcare Drug Manufacturers - Specialty & Generic

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

126% more call options, than puts

Call options by funds: $8.79M | Put options by funds: $3.9M

63% more capital invested

Capital invested by funds: $12.8M [Q1] → $20.9M (+$8.04M) [Q2]

11% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 28

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

0.36% more ownership

Funds ownership: 8.85% [Q1] → 9.21% (+0.36%) [Q2]

0% more funds holding

Funds holding: 200 [Q1] → 200 (+0) [Q2]

See Fund Rankings

Financial journalist opinion

Based on 15 articles about CGC published over the past 30 days

Zacks Investment Research

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Canopy Growth Appoints Tom Stewart as Chief Financial Officer

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that Tom Stewart has been appointed Chief Financial Officer, effective immediately. Mr. Stewart's appointment supports the continued execution of Canopy Growth's fiscal year 2026 strategy, which is marked by structural efficiency, operational and commercial.

Canopy Growth Appoints Tom Stewart as Chief Financial Officer

MarijuanaStocks

Best Canadian Marijuana Stocks for Traders and Investors Right Now

The Canadian cannabis sector remains important for investors seeking exposure to the growing U.S. marijuana market. The U.S. cannabis industry generated over $33 billion in sales during 2024 and is expected to surpass $50 billion by 2030. Growth is being fueled by increasing state-level legalization and consumer demand. Recently, headlines have focused on the progress of federal reform, including renewed discussions about rescheduling cannabis. This development could boost Canadian companies with U.S. partnerships or planned expansions. Investors are closely watching leading Canadian names that may benefit from both domestic strength and U.S. market opportunities.

Best Canadian Marijuana Stocks for Traders and Investors Right Now

Canopy Growth Strengthens Balance Sheet with Early US$25 Million Term Loan Prepayment

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it completed an early prepayment of US$25 million (the “Prepayment”) against the Company's senior secured term loan (the “Term Loan”). The Company previously entered into an agreement with certain of its lenders (the “Agreement”), which the Company anno.

Canopy Growth Strengthens Balance Sheet with Early US$25 Million Term Loan Prepayment

Introducing The VEAZY: STORZ & BICKEL's Most Compact and Accessible Vaporizer

TUTTLINGEN, Germany--(BUSINESS WIRE)--STORZ & BICKEL GmbH (“STORZ & BICKEL” or the “Company”), a world-leading manufacturer of high-end, medically certified cannabis vaporizers and a subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled the VEAZY— an accessible new addition to its premium portfolio, extending the Company's precision engineering to a broader audience. The VEAZY delivers an uncompromising solution, designed to be as approachable as it is easy t.

Introducing The VEAZY: STORZ & BICKEL's Most Compact and Accessible Vaporizer

Leading Independent Proxy Advisory Firm ISS Recommends Canopy Growth Shareholders Vote FOR All Resolutions

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (TSX: WEED) (NASDAQ:CGC) ("Canopy Growth" or the "Company") is pleased to announce that leading independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) has recommended Canopy Growth shareholders (“Shareholders”) vote “FOR” each of the resolutions to be approved at the upcoming Annual General and Special Meeting of Shareholders (the “Meeting”) to be held on Tuesday, September 26, 2025 at 1:00 p.m. ET. As an.

Leading Independent Proxy Advisory Firm ISS Recommends Canopy Growth Shareholders Vote FOR All Resolutions

MarijuanaStocks

3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025

The cannabis industry continues to demonstrate why it deserves the same opportunities as other legitimate businesses. From an investment side, there are many who have put up big money in various global regions to be a part of this booming industry. Places like Canada and the USA are where the main markets exist. Now there are several parts to this, both bitter and sweet. Here is why it could be a bit bitter is with the potential of cannabis being rescheduled, it will give a major leg up to corporate cannabis versus small batch mom and pop cultivators.

3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025

Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company's Financial Position

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the “ATM Program”) that allows Canopy Growth to issue and sell up to US$200 million of common shares of the Company (“Common Shares”) from treasury from time to time in concurrent public of.

Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company's Financial Position

24/7 Wall Street

Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?

Key Points in This Article: Cannabis stocks surged in 2018-2019 on federal legalization hopes but crashed as progress stalled.

Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?

Zacks Investment Research

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

See News Rankings

Charts implemented using Lightweight Charts™